Tafnat (Tenofovir Alafenamide) 25 mg Tablets (30 Count)
Tafnat is a cutting-edge antiviral drug for Hepatitis B treatment. Active ingredient: Tenofovir Alafenamide (25 mg), known as TAF.
Manufacturer: Natco Pharma (India). A premium generic version of Vemlidy.
The Natco Advantage:
Manufactured by one of the most trusted pharmaceutical companies in the world. Tafnat is a "prodrug" that transports the active substance directly into hepatocytes (liver cells). This allows for a minimal dose (25 mg) to be highly effective while sparing the kidneys and bones from toxicity associated with older treatments.
✅ Safety Profile: The best option for long-term lifelong therapy.
Indicated for the treatment of Chronic Hepatitis B virus (HBV) infection in adults and adolescents (12+ years).
It is the preferred regimen for patients with:
- Bone disease (osteopenia/osteoporosis).
- Renal impairment (kidney issues).
- History of long-term treatment with other antivirals.
Standard Dosage: One tablet (25 mg) taken orally once daily.
⚠️ Administration Instructions:
- 🍲 Take with food. Food enhances bioavailability.
- Do not discontinue abruptly. Stopping the medication can cause a severe acute exacerbation of Hepatitis B.
- Hypersensitivity to Tenofovir Alafenamide.
- Decompensated liver disease (Child-Pugh B or C).
- Breastfeeding.
- HIV Co-infection Warning: HIV antibody testing should be offered to all patients before starting therapy. Tafnat alone is not adequate for HIV treatment.
Tafnat has an excellent safety profile. Mild reactions may include:
- Headache.
- Abdominal pain.
- Fatigue.
- Cough.
It demonstrates significantly less impact on bone mineral density and renal function markers compared to TDF.
What Customers Say
No reviews yet
Your review can be the first!